Skip to Content


Genomic Medicine Program Advisory Committee, Notice of Meeting

Document Details

Information about this document as published in the Federal Register.

Enhanced Content

Relevant information about this document from provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

The Department of Veterans Affairs (VA) gives notice under the Federal Advisory Committee Act, 5 U.S.C., App. 2, that the Genomic Medicine Program Advisory Committee will meet on April 11, 2013, in Suite 1000 at the United States Access Board Conference Room, 1331 F Street NW., Washington, DC. The meeting will convene at 9 a.m. and adjourn at 5 p.m. The meeting is open to the public.

The purpose of the Committee is to provide advice and make recommendations to the Secretary of Veterans Affairs on using genetic information to optimize medical care of Veterans, and to enhance development of tests and treatments for diseases particularly relevant to Veterans.

The Committee will receive program updates and will continue to provide insight into optimal ways for VA to incorporate genomic information into its health care program while applying appropriate ethical oversight and protecting the privacy of Veterans. The meeting focus will be on expanding VA's infrastructure for storing and analyzing genomic data and updates on the status of the ongoing Million Veteran Program, as well as the clinical Genomic Medicine Service. The emerging implications of combining information from genetic data with data from publically available genealogy databases will also be discussed. The meeting will also receive an update on the status of the ongoing Million Veteran Program and the clinical Genomics Service. Public comments will be received at 3:30 p.m. and are limited to 5 minutes each. Individuals who speak are invited to submit a 1-2 page summary of their comments for inclusion in the official meeting record to Dr. Sumitra Muralidhar, Designated Federal Officer, 810 Vermont Avenue NW (10P9), Washington, DC 20420 or by email at Any member of the public seeking additional information should contact Dr. Muralidhar at (202) 443-5679.

Start Signature

By Direction of the Secretary.

Dated: March 21, 2013.

Vivian Drake,

Committee Management Officer.

End Signature End Preamble

[FR Doc. 2013-06980 Filed 3-26-13; 8:45 am]